MAPT and Alzheimer disease: Most neurodegenerative diseases which are associated with cognitive decline, such as Alzheimer’s Disease (AD), Progressive Supranuclear Palsy (PSP) and Frontotemporal Dementia (FTD) are accompanied by abnormal hyperphosphorylation and aggregation of tau protein [1, 2].